Novartis Institutes for BioMedical Research, Inc., 10% Owner at Surface Oncology, Inc. (SURF), bought 3,039,392 shares at $15.00 ($11.5M) on 2018-04-23, disclosed to the SEC on 2018-04-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,272,726 | $0 | 0.0% |
| 2 | $15.00 | 766,666 | $11.5M | 100.0% |
| Total | $3.78 avg | 3,039,392 | $11.5M | 100% |
| Filing → |